Sign in

CIK 0001600620

  • Large accelerated filer

Aurinia Pharmaceuticals Inc.

Sign in to watch
Ticker
AUPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981231763
Phone
+1 250-744-2487
Business address
#140, 14315 - 118 AVENUE, EDMONTON, Alberta, Canada, T5L 4S6
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$735,889
in 3 filings

Net −$735,889. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Robertson Stephen P. −$736K Chief Legal Officer sold 7% of stake
Date Insider Transaction Shares Price Value Owned after
2022-03-02 Huizinga Robert Bindert EVP of Research Grant or award +8,500 74,228
2022-03-02 Huizinga Robert Bindert EVP of Research Sale −4,849 $12.01 $58K 69,379
2022-03-02 Huizinga Robert Bindert EVP of Research Grant or award · Restricted Stock Unit +62,448 62,448
2022-03-02 Huizinga Robert Bindert EVP of Research Grant or award · Stock Option (right to buy) +106,838 106,838
2021-10-25 Huizinga Robert Bindert EVP of Research Option exercise +95,000 $3.20 $304K 195,728
2021-10-25 Huizinga Robert Bindert EVP of Research Sale −130,000 $29.75 $3.9M 65,728
2021-10-25 Huizinga Robert Bindert EVP of Research Option exercise · Stock Option (right to buy) −95,000 3,864
2021-09-21 Huizinga Robert Bindert EVP of Research Option exercise +16,000 $2.63 $42K 122,092
2021-09-21 Huizinga Robert Bindert EVP of Research Option exercise +11,136 $3.20 $36K 133,228
2021-09-21 Huizinga Robert Bindert EVP of Research Sale −27,136 $24.05 $653K 106,092
2021-09-21 Huizinga Robert Bindert EVP of Research Sale −5,364 $23.66 $127K 100,728
2021-09-21 Huizinga Robert Bindert EVP of Research Option exercise · Stock Option (right to buy) −16,000 0
2021-09-21 Huizinga Robert Bindert EVP of Research Option exercise · Stock Option (right to buy) −11,136 98,864
2021-09-14 Huizinga Robert Bindert EVP of Research Sale −22,500 $21.75 $489K 106,092
2021-09-10 Huizinga Robert Bindert EVP of Research Sale −5,000 $19.83 $99K 133,592
2021-09-10 Huizinga Robert Bindert EVP of Research Sale −5,000 $19.76 $99K 128,592
2021-09-07 Huizinga Robert Bindert EVP of Research Sale −5,000 $18.30 $92K 138,592
2021-05-11 Huizinga Robert Bindert Ex Vice President of Research Option exercise +40,000 $3.02 $121K 143,592
2021-05-11 Huizinga Robert Bindert Ex Vice President of Research Option exercise · Stock Option (right to buy) −40,000 0

Page 1 of 1 · 19 trades